Back to Search
GERARDO ROSAS, MD
MD
Hematology & Oncology Physician
NPI: 1912495664IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
T0909(TX)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
T0909(TX)
Education
OTHER
Class of 2018
Research & Publications (20)
An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.
PMID 19407730·CNS Spectr·2009
4-observational
DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.
PMID 19336528·Neuro Oncol·2009
7-preclinical
A placebo-controlled study evaluating the efficacy and safety of flexible-dose desvenlafaxine treatment in outpatients with major depressive disorder.
PMID 19169187·CNS Spectr·2009
3-trial
MMTV-cre-mediated fur inactivation concomitant with PLAG1 proto-oncogene activation delays salivary gland tumorigenesis in mice.
PMID 18425334·Int J Oncol·2008
7-preclinical
Prevalence of CYP2C19 gene polymorphisms in the Puerto Rican population: a preliminary report.
PMID 19069365·P R Health Sci J·2008
8-other
A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder.
PMID 18545056·Int Clin Psychopharmacol·2008
8-other
Renewed hope for a vaccine against the intestinal adult Taenia solium.
PMID 17918361·J Parasitol·2007
6-review
A new highly effective anticysticercosis vaccine expressed in transgenic papaya.
PMID 17399859·Vaccine·2007
7-preclinical
Taenia solium: identification and preliminary characterization of a lipid binding protein with homology to the SEC14 catalytic domain.
PMID 17324397·Exp Parasitol·2007
7-preclinical
Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine.
PMID 17188784·Vaccine·2007
6-review
A novel synthetic adjuvant effectively enhances the immunogenicity of the influenza vaccine.
PMID 16202486·Vaccine·2006
7-preclinical
Effective protection against experimental Taenia solium tapeworm infection in hamsters by primo-infection and by vaccination with recombinant or synthetic heterologous antigens.
PMID 16995407·J Parasitol·2006
7-preclinical
Intrahepatic DNA vaccination: unexpected increased resistance against murine cysticercosis induced by non-specific enhanced immunity.
PMID 16884018·J Parasitol·2006
7-preclinical
Correlation between oxidative stress and alteration of intracellular calcium handling in isoproterenol-induced myocardial infarction.
PMID 16820956·Mol Cell Biochem·2006
7-preclinical
Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity.
PMID 16697684·Microbes Infect·2006
7-preclinical
Preparation of AlFe nanoparticles by mechanical alloyed technique.
PMID 16430152·J Nanosci Nanotechnol·2005
8-other
Structure, stability and catalytic activity of chemically synthesized Pt, Au, and Au-Pt nanoparticles.
PMID 16004132·J Nanosci Nanotechnol·2005
8-other
Brucella spp. lumazine synthase: a novel antigen delivery system.
PMID 15780726·Vaccine·2005
7-preclinical
Milk folate but not milk iron concentrations may be inadequate for some infants in a rural farming community in San Mateo, Capulhuac, Mexico.
PMID 14522737·Am J Clin Nutr·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 7979 WURZBACH RD
SAN ANTONIO, TX 78229 - Phone
- (210) 450-1143
Quick Facts
- NPI
- 1912495664
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile